Jennifer Hu, MD
Ophthalmology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hu’s office at (408) 851-1000 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$30,771
Medicare paid this office $30,771 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 70 · Health risk score 2.29. Sicker patients than 9 in 10 peers; the typical ophthalmology clinician is at 1.16.
The office billed $110,785, Medicare allowed $39,357 and paid $30,771; for 135 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 11 | 135 | 70 | 2.29 | $110,785 | $30,771 |
| 2018 | 11 | 38 | 69 | 2.13 | $17,462 | $4,096 |
| 2016 | 13 | 21 | 70 | 1.68 | $7,386 | $1,317 |
| 2013 | 22 | 102 | 70 | 2.20 | $34,017 | $11,575 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2013: 3 services
| Established patient complete exam of visual system | 13 | $1,318 | $101 |
| Examination of eye by ophthalmoscope with retinal drawing | 14 | $562 | $20 |
| Imaging of retina | 11 | $417 | $35 |
Medicaid work
$109,597 in 2024
Medicaid paid $109,597 for 820 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravitreal injection of a pharmacologic agent (separate procedure) | 196 | $54,827 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 303 | $36,960 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 308 | $17,081 |
| Compounded drug, not otherwise classified | 13 | $729 |
| 2024 | 820 | 4 | 29 | $109,597 |
| 2023 | 194 | 2 | 17 | $0 |
| 2022 | 114 | 3 | 16 | $74 |
| 2019 | 72 | 1 | 14 | $0 |
| 2018 | 21 | 1 | 17 | $191 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 93 | $0 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 101 | $0 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 60 | $74 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 13 | $0 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 41 | $0 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 72 | $0 |
2018
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 21 | $191 |
Drugs they prescribed that Part D paid
$10,625
Pharmacies billed $10,625 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 274) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
225 generic and 49 brand-name prescriptions · $10,625 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Difluprednate | 11 | $2,318 | $211 |
| Prednisolone Acetate | 44 | $2,313 | $53 |
| Dorzolamide-Timolol | 33 | $779 | $24 |
| Diclofenac | 41 | $607 | $15 |
| Latanoprost | 27 | $390 | $14 |
See all 8 drugs
| Difluprednate | 11 | $2,318 | $211 |
| Prednisolone Acetate | 44 | $2,313 | $53 |
| Dorzolamide-Timolol | 33 | $779 | $24 |
| Diclofenac | 41 | $607 | $15 |
| Latanoprost | 27 | $390 | $14 |
| Brimonidine | 25 | $387 | $15 |
| Timolol Maleate | 19 | $367 | $19 |
| Erythromycin | 17 | $230 | $14 |
Year by year
| 2024 | 274 | 88 | 0% (0) | 18% | $10,625 |
| 2023 | 215 | 76 | 0% (0) | 14% | $12,758 |
| 2022 | 200 | 74 | 0% (0) | 21% | $10,859 |
| 2021 | 179 | 75 | 0% (0) | 8% | $9,695 |
| 2020 | 177 | 65 | 0% (0) | 12% | $9,784 |
| 2019 | 163 | 69 | 0% (0) | 20% | $12,300 |
| 2018 | 142 | 52 | 0% (0) | 15% | $5,573 |
| 2017 | 172 | 83 | 0% (0) | 20% | $7,945 |
| 2016 | 293 | 170 | 0% (0) | 20% | $13,203 |
| 2015 | 273 | 90 | 0% (0) | None | $11,523 |
| 2014 | 232 | 88 | 0% (0) | None | $9,315 |
| 2013 | 101 | 51 | 0% (0) | 31% | $5,686 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Prednisolone Acetate | 22 | $1,467 | $67 |
| Dorzolamide-Timolol | 29 | $658 | $23 |
| Diclofenac | 29 | $471 | $16 |
| Brimonidine | 31 | $414 | $13 |
| Timolol Maleate | 22 | $412 | $19 |
| Erythromycin | 25 | $384 | $15 |
| Latanoprost | 21 | $337 | $16 |
2022: 6 drugs
| Prednisolone Acetate | 35 | $1,776 | $51 |
| Dorzolamide-Timolol | 25 | $558 | $22 |
| Brimonidine | 38 | $503 | $13 |
| Latanoprost | 23 | $347 | $15 |
| Erythromycin | 23 | $335 | $15 |
| Diclofenac | 25 | $332 | $13 |
2021: 5 drugs
| Dorzolamide-Timolol | 20 | $581 | $29 |
| Brimonidine | 33 | $474 | $14 |
| Diclofenac | 29 | $432 | $15 |
| Latanoprost | 26 | $420 | $16 |
| Erythromycin | 22 | $297 | $14 |
2020: 6 drugs
| Prednisolone Acetate | 19 | $940 | $49 |
| Latanoprost | 32 | $721 | $23 |
| Brimonidine | 39 | $542 | $14 |
| Dorzolamide-Timolol | 14 | $421 | $30 |
| Diclofenac | 17 | $269 | $16 |
| Erythromycin | 12 | $226 | $19 |
2019: 4 drugs
| Prednisolone Acetate | 17 | $885 | $52 |
| Brimonidine | 40 | $522 | $13 |
| Latanoprost | 22 | $452 | $21 |
| Dorzolamide-Timolol | 15 | $371 | $25 |
2018: 4 drugs
| Prednisolone Acetate | 16 | $1,034 | $65 |
| Brimonidine | 35 | $453 | $13 |
| Latanoprost | 19 | $411 | $22 |
| Dorzolamide-Timolol | 17 | $300 | $18 |
2017: 5 drugs
| Prednisolone Acetate | 24 | $1,656 | $69 |
| Latanoprost | 26 | $549 | $21 |
| Brimonidine | 39 | $537 | $14 |
| Erythromycin | 11 | $191 | $17 |
| Diclofenac | 12 | $168 | $14 |
2016: 7 drugs
| Prednisolone Acetate | 38 | $2,590 | $68 |
| Latanoprost | 41 | $969 | $24 |
| Brimonidine | 54 | $880 | $16 |
| Erythromycin | 46 | $786 | $17 |
| Dorzolamide-Timolol | 15 | $382 | $25 |
| Neomycin-Polymyxin-Dexameth | 20 | $334 | $17 |
| Timolol Maleate | 11 | $181 | $16 |
2015: 6 drugs
| Prednisolone Acetate | 30 | $1,814 | $60 |
| Brimonidine | 64 | $1,811 | $28 |
| Latanoprost | 60 | $1,403 | $23 |
| Timolol Maleate | 33 | $595 | $18 |
| Dorzolamide-Timolol | 16 | $410 | $26 |
| Dorzolamide | 14 | $296 | $21 |
2014: 7 drugs
| Prednisolone Acetate | 43 | $2,608 | $61 |
| Latanoprost | 33 | $729 | $22 |
| Brimonidine | 37 | $564 | $15 |
| Ketorolac Tromethamine | 25 | $405 | $16 |
| Dorzolamide-Timolol | 11 | $295 | $27 |
| Timolol Maleate | 14 | $239 | $17 |
| Ofloxacin | 21 | $218 | $10 |
2013: 2 drugs
| Ofloxacin | 20 | $231 | $12 |
| Latanoprost | 11 | $166 | $15 |
Professional record
- NPI
- 1407090079
- Trained
- University of California, San Francisco School of Medicine, 2008
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 170 King St, Unit 211, San Francisco, CA, 94107
- NPI first listed
- 2009-04-28
- NPI last updated
- 2021-12-15
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.